2025年

Won the first prize of the 6th Foshan High tech Progress Award

2024年

Expansion of Shishan Branch: Warehouse Building Toppled, Supply Chain Capability Upgraded Again

2020年

Shishan Branch has become one of the first batch of GMP certified enterprises for new veterinary drugs in China, officially put into operation, and added three new veterinary drug certificates: Rifaximin Uterine Injection (lactation period), Ketoprofen Injection, and Telmisartan Oral Solution

2018年

R&D upgrade: Approved as a Class II new veterinary drug - Jiamimycin Injection

2017年

Establishing Shishan Branch and initiating capacity expansion; Obtained 3 new veterinary drug registration certificates: Ivermectin Chewable Tablets, Benazepril Hydrochloride Chewable Tablets, and Meloxicam Tablets

2016年

By virtue of its four major advantages in technology, equipment, service, and brand, it has been recognized as a "key agricultural leading enterprise" in Guangdong Province

2014年

Constructing a core intellectual property system through the transformation of technological achievements; Awarded the title of "High tech Enterprise".

2012年

Annual sales exceed 100 million yuan, entering the stage of large-scale development

2011-2015年

During the period of explosive R&D achievements, a total of 4 new veterinary drug registration certificates have been obtained: oxytetracycline uterine injection, compound amoxicillin breast injection, cefuroxime sulfate breast injection (lactation period), and cefuroxime sulfate breast injection (dry lactation period)

2010年

Relying on the advantages of the entire industry chain and leading product technology, we have successfully opened up the northern market and transformed into a national animal protection enterprise

2007年

Strengthen research and development innovation, establish scientific research cooperation with China Agricultural University, Huanong University, and Foshan University, and have been approved by the Guangdong Provincial Department of Science and Technology to establish the "Provincial Agricultural Science and Technology Innovation Center"

2006年

Launch the "Sales Northern Expedition Strategy" and propose the "Two Legs Walking" channel strategy, expanding the market in parallel with the construction of specialized large-scale breeding terminals and dealer networks.

2003年

The first batch passed the GMP certification of the Ministry of Agriculture and obtained the 26th GMP production and operation license nationwide, promoting industrial upgrading through GMP standardized production

2002年

Foshan Nanhai Dongfang Aolong Pharmaceutical Co., Ltd. has been officially established, embarking on a path of development in the field of insurance